We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Cancer Stem Cells May Be Cause of Brain Tumors

By Biotechdaily staff writers
Posted on 07 Jan 2008
Stem cells--commonly known as a source of biologic rejuvenation--may play harmful roles in the body, particularly in the growth and metastasis of cancer. First discovered in leukemia, stem cells have been detected in solid tumors found in pancreatic, prostate, colon, breast, and brain cancers.

On December 11, 2007, a symposium at the annual American Society of Hematology (ASH) meeting held in Atlanta, GA, USA, addressed the topic. Neurosurgeon researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center (New York, NY, USA) are conducting ongoing research evaluating methods to combat brain cancer stem cells. To stave off cancer stem cell growth in the brain, Dr. John Boockvar, chairman of medicine, New York-Presbyterian/Weill Cornell, is studying two drugs already available for cancer treatment. Early findings from these studies have shown that, that some patients' cancers are destroyed, while others' remain resistant. Dr. Boockvar believes that these patients' drug resistance might be due to a class of stem cells resistant to available treatments.

"Some patients' brain tumors respond to chemotherapy and some don't,” remarked Dr. Boockvar. "We believe cancer stem cells may be the cause.”


Related Links:
Weill Cornell Medical Center

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test

Latest BioResearch News

Circulating Tumor DNA Helps Identify Targets for Personalized Immunotherapy
07 Jan 2008  |   BioResearch

Researchers Classify 108 Lysosomal Disorders in Updated Diagnostic Framework
07 Jan 2008  |   BioResearch

New Autoantibody Target Identified in Neuromyelitis Optica Spectrum Disorder
07 Jan 2008  |   BioResearch